Safety and Effectiveness of Three Anti-HIV Drugs Combined in One Pill (Trizivir)
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to look at the safety and effectiveness of a pill called
Trizivir that is a combination of three anti-HIV drugs (zidovudine, lamivudine, and
abacavir). Zidovudine and lamivudine are often given combined in one pill (Combivir). In this
study, Trizivir will be compared to Combivir plus abacavir.
Phase:
Phase 3
Details
Lead Sponsor:
Glaxo Wellcome
Treatments:
Abacavir Dideoxynucleosides Lamivudine Lamivudine, zidovudine drug combination Zidovudine